Cite
HARVARD Citation
Yu, Y. et al. (2021). Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas. Neuro-oncology. 23 (11), pp. 1872-1884. [Online].